Valuation : MaaT Pharma

Market Cap 55.4M 64.38M 52.12M 47.62M 89.07M 6.08B 89.32M 616M 239M 3.12B 242M 236M 10.05B P/E 2026 *
-1.54x
P/E 2027 * -2.64x
Enterprise Value 66.7M 77.52M 62.76M 57.33M 107M 7.32B 108M 742M 288M 3.76B 291M 285M 12.1B EV / Sales 2026 *
6.84x
EV / Sales 2027 * 3.11x
Free-Float
36.85%
Yield 2026 *
-
Yield 2027 * -
1 day+0.17%
1 week-2.81%
Current month-0.68%
1 month+5.38%
3 months-0.17%
6 months-57.27%
Current year-38.88%
1 week 2.92
Extreme 2.92
3.08
1 month 2.76
Extreme 2.765
3.4
Current year 2.32
Extreme 2.32
8.62
1 year 2.32
Extreme 2.32
8.62
3 years 2.32
Extreme 2.32
9.96
5 years 2.32
Extreme 2.32
14.4
10 years 2.32
Extreme 2.32
14.4
Manager TitleAgeSince
Chief Executive Officer - 01/01/2014
Director of Finance/CFO 59 01/11/2024
Chief Tech/Sci/R&D Officer - 24/06/2024
Director TitleAgeSince
Director/Board Member - 01/01/2014
Director/Board Member 57 01/01/2014
Chairman - 01/01/2016
Date Insider Type Main position Quantity % Market Cap. Importance
5/28/26 A Buy

Founder

2,000 0.0106%
1/29/26 A
Seventure Partners SA
SellCompany 25,423 0.1356%
1/28/26 A
Seventure Partners SA
SellCompany 57,964 0.3091%
Change 5-day change 1-year change 3-year change Capi.($)
+0.17%-2.81%-27.41%-53.18% 64.38M
-1.79%-2.27%+50.90%+89.03% 67.98B
-2.06%-0.18%+41.53%+88.17% 64.94B
-0.31%+6.54%-11.39%+457.82% 27.58B
-3.00%-2.90%+39.40%+9.41% 25.74B
+0.86%+1.65%+0.25%-14.78% 26.06B
-1.46%+0.42%+24.07%-18.70% 20.09B
-2.96%-15.21%+210.71%+370.84% 17.16B
-1.49%-4.88%-0.41%+530.26% 14.92B
-0.20%+8.37%+57.87%+159.50% 14.62B
Average -1.22%-0.05%+38.55%+161.84% 27.92B
Weighted average by Cap. -1.52%+0.18%+42.27%+145.03%

Financials

2026 *2027 *
Net sales 9.75M 11.33M 9.17M 8.38M 15.68M 1.07B 15.72M 108M 42.07M 549M 42.55M 41.62M 1.77B 28.88M 33.56M 27.17M 24.82M 46.43M 3.17B 46.56M 321M 125M 1.63B 126M 123M 5.24B
Net income -31.69M -36.83M -29.82M -27.24M -50.96M -3.48B -51.1M -352M -137M -1.78B -138M -135M -5.75B -15.31M -17.79M -14.41M -13.16M -24.62M -1.68B -24.68M -170M -66.05M -862M -66.81M -65.36M -2.78B
Net Debt 11.3M 13.14M 10.64M 9.72M 18.18M 1.24B 18.22M 126M 48.77M 636M 49.33M 48.25M 2.05B 34.5M 40.09M 32.46M 29.65M 55.47M 3.79B 55.62M 384M 149M 1.94B 151M 147M 6.26B
Logo MaaT Pharma
MaaT Pharma is a late-stage biotechnology company and a leader in the development of intestinal microbiota-based drugs designed to modulate the immune system of cancer patients and improve their survival. A pioneer in its field, MaaT Pharma is developing the first immunomodulatory drug candidate based on intestinal microbiota in oncology, currently in phase 3 clinical evaluation. Thanks to its proprietary pooling (combining donations of healthy microbiota) and microbial co-culture technologies, MaaT Pharma is developing standardised drugs with high bacterial diversity, aimed at improving the survival of cancer patients.
Employees
56
Date Price Change Volume
04/09/26 €2.940 +0.17% 25,902
03/09/26 €2.935 -0.84% 13,621
02/09/26 €2.960 -1.50% 7,517
01/09/26 €3.005 +1.52% 27,930
31/08/26 €2.960 -2.15% 24,554
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
2.940EUR
Average target price
6.500EUR
Spread / Average Target
+121.09%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MAAT Stock